Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-01

Clinical Trial Update: Psilocybin-facilitated Treatment for Cocaine Use [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating psilocybin-facilitated treatment for cocaine use disorder has completed at the University of Alabama at Birmingham.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED